Ares Financial Consulting’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Ares Financial Consulting's WST Position: Q3 2026 in Review
Ares Financial Consulting reduced its West Pharmaceutical (WST) stake by 6.1% in Q3 2026, selling an estimated $3.53K and leaving 153 shares worth $56.7K. The position accounts for 0.04% of the portfolio, ranked #213.
Ares Financial Consulting first reported a position in WST in Q4 2025 and has held it in 4 quarters since. The position peaked at $58.5K in Q2 2026. 878 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Ares Financial Consulting held 153 shares of West Pharmaceutical worth $56.7K as of Q3 2026.
- Ares Financial Consulting sold 10 West Pharmaceutical shares in Q3 2026, an estimated $3.53K.
- West Pharmaceutical made up 0.04% of Ares Financial Consulting's portfolio in Q3 2026, its #213 holding.
- Ares Financial Consulting first reported a position in West Pharmaceutical in Q4 2025 and has held it in 4 quarters since.
- Ares Financial Consulting's West Pharmaceutical position peaked at $58.5K in Q2 2026.
- 878 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.